Strengthening the bonds
that matter most
Building the framework to re-define pediatric diagnostics
through integrated partnerships learn more
family in field of grass
Answers in Weeks,
Not Years
Discover the power of the orthogonal approach
and the CLARITAS Experience learn more
closeup of woman's face
Learn how the CLARITAS Experience brought Jackie's
32 year diagnostic odyssey to an end learn more
kids playing on beach
Fast. Confirmed.
Claritas Clinical Exome: Orthogonally-confirmed,
clinically-relevant results within 12 weeks learn more
  • October 27, 2016

    Claritas Genomics employees presented three posters at ASHG 2016 in Vancouver, Canada. John Thompson, PhD and Chief Technology Officer, presented on "Improved sensitivity for clinically relevant variants using orthogonal sequencing." Eric White, PhD and Director of Assay and Technology Development, presented on "Improving coverage of poorly sequenced regions in clinical exomes." Natalie Vena, GC and Genetic...

  • October 12, 2016

    Claritas Genomics’ Elizabeth Mullady, MLS(ASCP), MHA, Director of Quality Assurance and Regulatory Affairs speaks on October 18, 2016 at the 10th annual Lab Quality Confab in New Orleans. Ms. Mullady and co-presenter Randall Querry of the American Association for Laboratory Accreditation discuss “Lessons Learned at Claritas from Simultaneous Accreditation to CLIA and ISO 15189: Combining the World’s Most Accepted QMS with CLIA.” Read more about their talk by visiting...

  • October 04, 2016

    Join John Thompson, PhD, Chief Technology Officer at Claritas Genomics; Natalie Vena, Genetic Counselor at Claritas Genomics; and David Miller, MD, PhD, Medical Director at Claritas Genomics and Clinical Geneticist at Boston Children's Hospital as they discuss the technology of whole exome testing, the algorithms used by clinicians when considering whether to order genetic testing, and case studies showing the utility of whole exome sequencing.

    This webinar, recording June 28, 2016 is available...

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.